A Clinical Study to Evalaute the Effect of Bilvaphala majja Avaleha in the Management of "Garbhini Chardi"(Emesis Gravidarum)

An Open Label Single Arm Clinical Study to Evaluate The Effect of Bilvaphala majja Avaleha in the Management of "Garbhini Chardi"(Emesis Gravidarum)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053804

Enrollment

Registered

2023-06-13

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O210- Mild hyperemesis gravidarum

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting pratyatmalakshanas of garbini in 1st trimester (upto 12 weeks) with chardi as main symptoms Both primi and multigravida in their 1st trimester Patients with reproductive age of 21years to 34years Patients with UrinePregnancyTest (UPT)- Positive.

Exclusion criteria

Exclusion criteria: 1 Hyperemesis gravidarum 2 Pregnant women below the age of 21years and above 35years (Elderly primi gravida) 3 Women with molar pregnancy and ectopic pregnancy 4 Pregnant women diagnosed with systemic illness like diabetes, hypertension, peptic disorders, pancreatitis, appendicitis, hepatic disorders.

Design outcomes

Primary

Measure	Time frame
Improvement in nausea Improvement in tiredness Improvement in appetite Improvement in weight Improvemnt in vomitingTimepoint: baseline, day fifteen & day 30	—

Secondary

Measure	Time frame
Increase in weightTimepoint: baseline to end point	—

Countries

India

Contacts

Public ContactDr Kanchana S Pol

Rajiv Gandhi University of Health Science Bangalore

dranusham@sdmayurbangalore.in8105777424

Outcome results